Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heyilimu Palashati

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Cancer|August 29, 2018
TCR repertoire intratumor heterogeneity of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in centers and margins of localized lung adenocarcinomasChaoting Zhang, Huirong Ding, Hongying Huang, et al.
Carcinogenesis|September 12, 2018
Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapyChaoting Zhang, Heyilimu Palashati, Qin Tan, et al.
Molecular Cancer|November 21, 2020
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignanciesChaoting Zhang, Heyilimu Palashati, Zhuona Rong, et al.
Nature Immunology|August 27, 2025
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumorsMaria Stadheim Eggebø, Julia Heinzelbecker, Heyilimu Palashati, et al.
Cancer Research|May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope ProductionRemco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Blood|March 2, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myelomaKarolos Douvlataniotis, Aleksei Titov, Julia Zeun, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Cancer|August 29, 2018
TCR repertoire intratumor heterogeneity of CD4<sup>+</sup> and CD8<sup>+</sup> T cells in centers and margins of localized lung adenocarcinomasChaoting Zhang, Huirong Ding, Hongying Huang, et al.
Carcinogenesis|September 12, 2018
Immediate and substantial evolution of T-cell repertoire in peripheral blood and tumor microenvironment of patients with esophageal squamous cell carcinoma treated with preoperative chemotherapyChaoting Zhang, Heyilimu Palashati, Qin Tan, et al.
Molecular Cancer|November 21, 2020
Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignanciesChaoting Zhang, Heyilimu Palashati, Zhuona Rong, et al.
Nature Immunology|August 27, 2025
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumorsMaria Stadheim Eggebø, Julia Heinzelbecker, Heyilimu Palashati, et al.
Cancer Research|May 7, 2026
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope ProductionRemco Nagel, Adva Kochavi, Karine Flem-Karlsen, et al.
Blood|March 2, 2026
TCR T cells targeting IgA- and IgG-expressing multiple myelomaKarolos Douvlataniotis, Aleksei Titov, Julia Zeun, et al.
Cancer Cell|March 28, 2025
Translation dysregulation in cancer as a source for targetable antigensChen Weller, Osnat Bartok, Christopher S McGinnis, et al.
Pageof 1